The Effect of Short Term Solifenacin for Overactive Bladder on the Female Urinary Microbiome

Trial Profile

The Effect of Short Term Solifenacin for Overactive Bladder on the Female Urinary Microbiome

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Overactive bladder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Oct 2015 Trial design has been changed from cohort, observational to interventional, open, parallel as reported by ClinicalTrials.gov record.
    • 30 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 08 Sep 2014 Planned End Date changed from 1 Jul 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top